Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels

NCT02867020 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Apalutamide
DRUG: Abiraterone
DRUG: ADT
DRUG: Prednisone

Sponsor

Latin American Cooperative Oncology Group

Collaborators

[object Object]